Myocarditis Risk

Study Pinpoints Immune Signals Behind Rare Myocarditis After mRNA COVID Vaccines

Preclinical work ties CXCL10 plus interferon gamma to cardiac injury, pointing to cytokine blockers or genistein as possible mitigations.